Day One Biopharma to be acquired by Servier for $2.5B
Source: SeekingAlpha
2026-03-06 09:07:21 ET
More on Day One Biopharmaceuticals
- Day One Biopharmaceuticals: 'Strong Buy,' Several 2026 Milestones In Play Plus OJEMDA Growth
- Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead
- Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript
- Day One Biopharmaceuticals gains amid takeover speculation
- Day One Biopharmaceuticals reiterates $225M–$250M OJEMDA revenue target as pipeline expands with Emi-Le integration
Read the full article on Seeking Alpha
For further details see:
Day One Biopharma to be acquired by Servier for $2.5B
Jazz Pharmaceuticals plc
NASDAQ: JAZZ
JAZZ Trading
2.25% G/L:
$187.91 Last:
283,564 Volume:
$186.05 Open:
JAZZ Latest News
February 24, 2026 04:05:00 pm
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
JAZZ Stock Data
$10,064,526,163
58,152,216
1.22%
231
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 4
